INTRODUCTION
============

Termination of transcription by RNA polymerase II (RNAP II) is an important step of gene regulation in eukaryotes ([@B1]). Whereas premature transcription termination produces truncated and defective transcripts, expression of downstream genes is impaired if transcription reads through from upstream terminators ([@B2; @B3; @B4]). Transcription termination is coupled to 3′-end processing of mRNA in which cleavage and polyadenylation are performed by a multiprotein complex that contains cleavage and polyadenylation specificity factors (CPSF) and cleavage factor I (CFI) ([@B2],[@B3]). Two models known as the \`torpedo' and 'anti-terminator' models have been proposed to explain the mechanism of transcription termination. According to the 'torpedo' model, cleavage of RNA at the poly(A) site triggers rapid degradation of the 3′ RNA by exonuclease Rat1p and subsequent release of RNAP II ([@B4; @B5; @B6]). In the \`anti-terminator' model, transcription through the poly(A) site evokes a conformational change in the elongation complex, involving recruitment of CPSF and CFI and attendant release of positive elongation factors and antitermination factors. The resulting decrease in the processivity of RNAP II provokes transcription termination ([@B2]). Termination on many genes was found to occur at various positions depending on the growth conditions ([@B7]), and cryptic termination sites rich in AU nucleotides are frequently found within open reading frames (ORFs) ([@B8],[@B9]). Therefore, the selection of transcription termination sites is not determined solely by *cis*-acting sequence elements at the termination site and, plausibly, might also be regulated by post-translational modifications of termination and antitermination factors. However, the exact mechanism of selecting transcription termination sites is not fully understood.

Npl3p is a heterogeneous nuclear ribonucleoprotein with serine/arginine (SR) repeats. Its multiple functions include the role of an antiterminator to impede transcription termination at cryptic termination sites ([@B8]). According to the current model, Npl3p prevents transcription termination by competing with RNA cleavage factors, e.g. Hrp1p and Rna15p, for binding to nascent transcripts ([@B8],[@B9]). Npl3p exhibits a higher affinity for RNA than do Hrp1p and Rna15p ([@B9]), and hence functions as a physical barrier impeding the binding of Hrp1p and Rna15p to nascent transcripts. On the other hand, Hrp1p and Rna15p, but not Npl3p, prefer AU-rich sequences, a characteristic of strong termination sites ([@B9],[@B10]). Npl3p will thus be displaced by Hrp1p and Rna15p at strong termination sites, leading to the recruitment of other termination factors and cleavage of the nascent transcript. Since the competition between Npl3p and Hrp1p determines the choice of transcription termination sites ([@B7]), it would be of great interest to understand how transcription termination is regulated via post-translational modifications of Npl3p.

Transcription termination has to be well-coordinated with other steps of transcription, particularly elongation ([@B1]). As such, the elongation rate can influence termination through the action of positive elongation factors such as Spt4p, Spt6p and Paf1p, which are known to inhibit termination ([@B1],[@B8]). Consistent with the concept that elongation and termination are co-regulated; Npl3p can interact with RNAP II and stimulate transcription elongation directly *in vitro* ([@B11]). However, it is not understood whether Npl3p promotes transcription elongation *in vivo*. In addition, the mechanisms by which Npl3p modulates transcription elongation and coordinates it with termination remain to be elucidated.

RNA-binding affinity and cellular localization of Npl3p can be modulated by post-translational modifications, including methylation (in the nucleus) ([@B12],[@B13]) and phosphorylation (mainly in the cytoplasm) ([@B14],[@B15]). Although RNA binding by Npl3p *in vivo* is apparently unaffected by arginine methylation ([@B12]), hypophosphorylation and methylation of Npl3p are suggested to be important for its export together with mRNA from the nucleus ([@B12],[@B15; @B16; @B17]). Interestingly, phosphorylation of Npl3p by casein kinase II (CK2) was also suggested to contribute to Npl3p dissociation from the nascent transcript and hence to promote the recruitment of termination factor Rna15p *in vitro* ([@B11]). Npl3p is most heavily methylated in the nucleus ([@B13],[@B15]), and there is evidence that its methylation is important in nuclear export of the Npl3-mRNA complex ([@B12],[@B13]) and also in splicing ([@B18]). However, the role of Npl3p methylation in its transcription antitermination function is unclear.

Hmt1p is an arginine methyltransferase that catalyzes the methylation of arginine residues in several mRNA-binding proteins including Npl3p to facilitate their export from the nucleus ([@B12],[@B13]). Methylation by Hmt1p also weakens Npl3p association with Tho2p, a subunit of the THO and TREX complexes, which stimulate elongation and mRNA nuclear export, respectively ([@B13]). Replacement of all 15 arginines in Npl3p's Arg--Gly--Gly (RGG) repeats with lysines (the Npl3RKp variant) reduces Npl3p's interaction with Tho2p and restores its nuclear export in *hmt1Δ* cells. This finding suggested that methylation masks the RGG repeats, and that lysine substitutions partially mimic methylation to permit Npl3p dissociation from Tho2p and its nuclear export in the absence of Hmt1p ([@B12],[@B13]). Because Npl3RKp also restores nuclear export of Hrp1p in *hmt1Δ* cells, it appears that methylation of Npl3p, but not of Hrp1p itself, is crucial for Hrp1p export ([@B12]).

In this study, we hypothesized that Hmt1p might affect the selection of transcription termination sites by influencing the recruitment of Npl3p or Hrp1p to sites of transcription. We provide evidence that methylation of the RGG repeats in Npl3p by Hmt1p promotes antitermination at a weak terminator, and that it also stimulates elongation at least partly by stimulating Tho2p recruitment to sites of transcription. Our results suggest that the ability of Hmt1p to regulate the interaction between Npl3p and Tho2p on nascent mRNAs might provide an important feedback mechanism to couple the rate of transcription elongation with that of mRNA nuclear export.

MATERIALS AND METHODS
=====================

Yeast strains and growth conditions
-----------------------------------

All yeast strains and plasmids used in this work are listed in [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively. The BY4741 deletion derivatives were described earlier ([@B19]) and purchased from Open Biosystems. The presence of all reported deletion alleles was confirmed by PCR amplification and complementation of mutant phenotypes by plasmid-borne WT genes. Myc-tagged strains were constructed as described ([@B20]). *gal10-Δ56* mutants were constructed as detailed elsewhere ([@B21]). The *P~GAL1~*-*YLR454*w strains were constructed as described earlier ([@B22]). All strains were verified by PCR analysis. Table 1.List of yeast strainsNameParentRelevant GenotypeReferenceBY4741*mat***a** *his3*-Δ*1 leu2*-Δ*0 met15*-Δ*0 ura3*-Δ*0*3171BY4741*hmt1Δ::KanMX4*Open BiosystemsCMY201BY4741*hmt1Δ::KanMX4 NPL3-myc~13~*This workCMY202BY4741*hmt1Δ::KanMX4 THO2-myc~13~*This workCMY203BY4741*hmt1Δ::KanMX4 HRP1-myc~13~*This workCMY127BY4741*gal10-Δ56*([@B23])CMY223BY4741*hmt1Δ::KanMX4 gal10-Δ56*This workCMY129BY4741*npl3Δ::KanMX4 gal10-Δ56*([@B23])CMY125BY4741*P~GAL1~*-*YLR454w*This workCMY130BY4741*hmt1Δ::KanMX4 P~GAL1~-YLR454w*([@B23])W303*mat*α *leu2 ura3 lys2 trp1 his3*YAM533W303*hmt1Δ::HIS3 NPL3-myc::URA3*([@B13])YAM534W303*hmt1Δ::HIS3 npl3RK- myc::URA3*([@B13])YAM535W303*NPL3-myc::URA3*([@B13]) Table 2.List of plasmidsOriginal nameRelevant componentsReferences*npl3RK*pAM409*CEN LEU2 pNop-PrA-npl3-RK1-15\**([@B15])*NPL3*pPS2389*CEN LEU2 pNop-PrA-NPL3\**([@B13])*hmt1-G68R*pPS1752*CEN LEU2 hmt1-G68R*([@B32])*hmt-G68A*pPS1753*CEN LEU2 hmt1-G68A*([@B32])*HMT1*pPS1305*CEN LEU2 HMT1*([@B32])pSCh202pSCh202*2µ URA3 P~GAL~-PHO5*([@B25])pSCh209*-LAC4*pSCh209*-LAC42µ URA3 P~GAL~-PHO5::LAC4*([@B25])[^1]

Biochemical methods
-------------------

The ChIP experiments were conducted as described earlier ([@B23]) using the primers listed in [Table 3](#T3){ref-type="table"}. Northern blot analysis of total RNA was carried out as described earlier ([@B23]). Western blot analysis of whole-cell extracts was conducted using extracts prepared by trichloroacetic acid precipitation ([@B24]). Antibodies employed were monoclonal anti-Myc (Roche), anti-Rpb3p (Neoclone) and anti-Pgk1p (Invitrogen). GLAM assay was conducted as described earlier ([@B25]). Table 3.List of primersGene (region)Location (relative to ATG)SequenceReferences*P~GAL1~-YLR454w*    TATA−194/+355′-CTGGGGTAATTAATCAGCGAAGCGATG-3′([@B22])5′-CACTTGTACAGTAGAACATTAATCGGAAAC-3′    2 kb+1986/+21995′-CATATCATCCACCCTAGGTGCTAGGTCGG-3′([@B22])5′-GAGCTGACCAGACCTAACCATAGTAGCGTG-3′    4 kb+4069/+42685′-AGATATTACTCGTTGTTCGTGCCCAG-3′([@B22])5′-CCCAAAACCCTAGTTAACAGAAGGATC-3′\*    6 kb+5904/+60745′-CGTACTGTTGAAATGGAACGAGGACGC-3′([@B22])5′-ATCGCTTCCATACTCGTTGTATCATCAGTC-3′    8 kb+7701/+78505′-GAGGGTCACAGATCTATTACTTGCCC-3′([@B22])5′-GTTGTGAGTTGCTTCAGTGGTGAAGTG-3′    *Chr I*N.A.5′-GTTTATAGCGGGCATTATGCGTAGATCAG-3′([@B22])5′-GTTCCTCTAGAATTTTTCCACTCGCACATTC-3′*GAL10-GAL7*    *A*−58/+1825′-TTAAACTTCTTTGCGTCCATCC-3′([@B8])5′-TGCTTGGTCAAGACCTCTAACC-3′    *B*+823/+11085′-TGTCGTGAGTGGAACTTGGGTT-3′([@B8])5′-GCATATCTTCAGCGGAAAATCTGGC-3′    C+1869/+21025′-TGTCAAGGTTTTCATCCCGATTC-3′This work5′-AAGAAGGATAGTAAGCTGGCAA-3′    *D*+2323/+26045′-ATGGACGGTAGCAACAAGAATA-3′([@B8])5′-TGGGTTAAGGAAAATGACAGAA-3′    *E*−203/+385′-CAAAAAGCGCTCGGACAACT-3′([@B8])5′-TGGGAATGGCTAGAAAAATCAA-3′    *Chr V*N.A.5′-GGCTGTCAGAATATGGGGCCGTAGTA-3′([@B8])5\'-CACCCCGAAGCTGCTTTCACAATAC-3′[^2]

RESULTS
=======

Deletion of *HMT1* increases termination at the defective terminator of *gal10-Δ56 in vivo*
-------------------------------------------------------------------------------------------

Deletion of *HMT1* is synthetically lethal with deletion of *NPL3* ([@B13],[@B26; @B27; @B28]) or *CBP80* ([@B26]). Npl3p can stimulate elongation *in vitro* ([@B11]) and it inhibits termination *in vivo* ([@B8],[@B9]). Cbp80p has also been shown to promote antitermination *in vivo* ([@B23],[@B29]). Therefore, we hypothesized that Hmt1p might play a role in transcription elongation or antitermination. To test this hypothesis, the effect of *hmt1Δ* on transcription of the *gal10-Δ56* allele was examined. The Δ*56* mutation eliminates 55 bp at the 3′ end of *GAL10* and reduces the efficiency of 3′-end formation at the correct site, allowing read-through (*RT*) into the *GAL7* gene downstream. Gal7p is not expressed from the *RT* bicistronic transcript, and the production of native *GAL7* mRNA is impaired by transcription elongation across the *GAL7* promoter---both features contributing to the Gal^--^ phenotype of *gal10-Δ56* cells ([Figure 1](#F1){ref-type="fig"}A) ([@B21]). Figure 1.Hmt1p reduces termination at the defective *gal10-Δ56* terminator. (**A**) Diagram summarizing results in (**B**) and (**C**) indicating that *hmt1Δ* increases termination at the *gal10-Δ56* terminator, reducing the *RT* transcript while increasing *GAL7* transcript abundance, thereby suppressing the Gal^−^ phenotype in *gal10*-Δ56 cells. (B) Serially diluted strains of the indicated genotypes were spotted on synthetic complete medium lacking leucine (SC-LEU) plates containing 2% glucose (left) or 2% galactose (right) and incubated for 4 days. (C) Upper panel: northern blot analysis of *GAL7* and *RT* transcripts. Total RNA (20 µg) from indicated strains induced with 2% galactose for 3 h were resolved and probed for *GAL7* mRNA. The *GAL7/RT* ratios were determined by densitometry. The values indicated are the means and standard deviations of ratios calculated from three replicate experiments, which gave highly similar results. Lower panel: ethidium bromide staining of the gel.

In agreement with previous findings, *gal10-Δ56* cells could not grow on galactose medium ([Figure 1](#F1){ref-type="fig"}B, Row 3 versus 1) ([@B23]). Interestingly, *hmt1Δ gal10-Δ56* cells were able to grow on galactose medium ([Figure 1](#F1){ref-type="fig"}B, Row 4 versus 3). The Gal^+^ phenotype of *hmt1Δ gal10-Δ56* cells could be complemented with plasmid-borne wild-type *HMT1* ([Figure 1](#F1){ref-type="fig"}B, Row 7 versus 4), but not by *hmt1-G68A* or *hmt1-G68R* ([Figure 1](#F1){ref-type="fig"}B, Rows 5 and 6 versus 7), whose products exhibit weakened or no arginine methyltransferase activity, respectively ([@B13]). Northern blot analysis confirmed that the Gal^+^ phenotype of *hmt1Δ gal10-Δ56* cells could be attributed to an increased level of *GAL7* mRNA level and a reduced amount of *GAL10-GAL7 RT* transcript; as such, the ratio of *GAL7* to *GAL10-GAL7* RT transcripts (*GAL7/RT*) was increased more than 2-fold in *hmt1Δ gal10-Δ56* cells ([Figure 1](#F1){ref-type="fig"}C, lane [4](#F4){ref-type="fig"} versus 2). This suggests that elimination of Hmt1p increases termination at the defective *gal10-Δ56* terminator. Figure 2.*hmt1Δ* reduces the rate of transcription elongation *in vivo*. (**A**) Diagram of the P*~GAL1~-YLR454w* gene with positions of PCR primers indicated (in bp) from nucleotide A of the start codon. (**B**, **C**) Quantification of Rpb3p occupancy measured by ChIP with antiRpb3p antibodies at the five positions across *P~GAL1~-YLR454w* indicated in (A) for *HMT1* (CMY125) (B) or *hmt1Δ* (CMY130) (C). Cells grown in YP containing galactose were treated with 4% glucose for the indicated times. DNA extracted from immunoprecipitates and input chromatin samples was amplified by PCR in the presence of \[^33^P\]dATP for the different regions of *P~GAL1~-YLR454w*, together with a fragment from a non-transcribed region of *Chr I* to control for non-specific immunoprecipitation. PCR products were quantified with by phosphorimaging and ratios of experimental-to-control signals in the immunoprecipitates were normalized for the corresponding ratios for input samples to yield the occupancy values. Occupancies were normalized to those derived from cells grown in 2% galactose for 2 h (time = 0). (**D**) *hmt1Δ* does not detectably affect RNAP II processivity *in vivo. HMT1* and *hmt1Δ* cells were grown in galactose medium (time = 0) and quantification of Rpb3p occupancy was performed as above. The value at each position was normalized to that of the *WT* strain. (**E−G**) Methyltransferase activity of Hmt1p stimulates the rate of transcription elongation *in vivo. hmt1*Δ cells containing empty vector (*E*) or plasmids harboring *hmt1-G68R* (*F*) or *HMT1* (*G*) were induced with SC-LEU 2% galactose for 2 h (time = 0) and treated with 4% glucose for the indicated times. ChIP analysis of Rpb3p across the *P~GAL1~-YLR454w* gene was conducted as described earlier. Average results obtained from two independent cultures and two PCR amplifications for each culture were plotted in the histograms. Figure 3.Loss of *HMT1* affects Npl3p and Hrp1p occupancies at activated *GAL10-GAL7*. (**A**) Diagram of the *GAL10-GAL7* locus, with PCR primer pairs indicated with black bars and terminator labeled as 'T'. (**B**) ChIP analysis of Npl3p (*upper panel*) and Hrp1p (*middle panel*) occupancies across the *GAL10-GAL7* locus. ChIP analysis of Myc-Npl3p or Myc-Hrp1p occupancies was conducted using antimyc antibodies as described in [Figure 2](#F2){ref-type="fig"}, except using primers to amplify different regions of *GAL10-GAL7* in panel A and to amplify non-transcribed region of *Chr V* was conducted to control for non-specific immunoprecipitation. *Upper panel*, transformants of *hmt1Δ NPL3-myc* strain (CMY201) containing empty vector (Lanes 1--5), or plasmids harboring *hmt1-G68A* (Lanes *6--10*), *hmt1-G68R* (Lanes 11--15) or *HMT1* (Lanes 16--20) were grown in SC-LEU galactose medium. *Middle panel*, transformants of *hmt1Δ HRP1-myc* strain (CMY203) harboring the same plasmids described for the upper panel were analyzed as described earlier. *Lower panel*: Analysis of input chromatin samples for the CMY201 transformants. (**C**) Quantification of Npl3p occupancy measured at the indicated positions. The ratios of experimental-to-control signals in the immunoprecipitate samples (B, upper panel) were normalized for the corresponding ratios for input samples (B, lower panel) to yield the occupancy values*.* Average results obtained from two independent cultures and two PCR amplifications for each culture were plotted. (**D**) Possible effect of mutation or deletion of *HMT1* on expression of Myc-tagged Npl3p was analyzed by western blot analysis of WCEs of the relevant strains with antiMyc and antiPgk1p antibodies (to provide a loading control). (**E**) Quantification of Hrp1p occupancy measured at the indicated positions. The ratios of experimental to-control signals in the immunoprecipitate samples (B, middle panel) were normalized for the corresponding ratios for input samples (B, lower panel) to yield the occupancy values*.* Average results obtained from two independent cultures and two PCR amplifications for each culture were plotted. (**F**) Possible effect of mutation or deletion of *HMT1* on expression of Myc-tagged Hrp1p was analyzed by western blot analysis of WCEs of the relevant strains with antiMyc and antiPgk1p antibodies (to provide a loading control). Figure 4.Npl3RKp suppresses the antitermination and elongation rate defects caused by deletion of *NPL3* or *HMT1*. (**A**) ChIP analysis of Npl3p or Npl3RKp in *HMT1* or *hmt1Δ* strains. *HMT1 NPL3-myc* (YAM535, Lanes 1−5), *hmt1*Δ*NPL3-myc* (YAM533, Lanes 6−10) and *hmt1*Δ*npl3RK-myc* (YAM534, Lanes 11−15) were analyzed and the Npl3p or Npl3RKp occupancies across the *GAL10-GAL7* locus were determined as described in [Figure 3](#F3){ref-type="fig"}. Average results obtained from two independent cultures and two PCR amplifications for each culture were plotted. (**B**) Npl3RKp suppresses the Gal^+^ phenotype (antitermination defect) of *npl3*Δ*gal10-Δ56* (CMY129) cells. *npl3*Δ*gal10-Δ56* cells transformed with empty vector, *NPL3* or *npl3RK* plasmid were spotted on YP plates containing either 2% glucose (Glu, *left panel*) or 2% galactose (Gal, *right panels*) as carbon source and incubated for 3 days in YP. Note that YP was used instead of SC-LEU medium because the extreme slow-growth phenotype conferred by *npl3*Δon SC-LEU+Gal medium, evident in *GAL10* cells, obscures suppression of the Gal^−^ phenotype of *gal10-Δ56* by *npl3*Δ(data not shown). (**C**) Northern blot analysis of *GAL7* and *GAL10-GAL7 RT* mRNAs conducted as in [Figure 1](#F1){ref-type="fig"}C. The values indicated are the means and standard deviations of ratios calculated from three replicate experiments, which gave highly similar results. (**D**) Npl3RKp suppresses the Gal^+^ phenotype (antitermination defect) of *hmt1*Δ*gal10-Δ56* (CMY223) cells. *HMT1 gal10-Δ56* and *hmt1*Δ*gal10-Δ56* strains with plasmid-borne *NPL3* or *npl3RK* were spotted on SC-LEU plates containing 2% glucose (left) or 2% galactose (right) and incubated for 4 days. (**E**) ChIP analysis of Rpb3p occupancy across the *P~GAL1~-YLR454w* locus after imposing glucose repression. *hmt1Δ* cells (CMY130) with or without plasmid-borne *npl3RK* were induced with 2% galactose for 2 h (time = 0) and treated with 4% glucose for the indicated times. ChIP assays were done as described in [Figure 2](#F2){ref-type="fig"}. PCR amplifications of input chromatin samples are labeled 'In'; non-coding region on chromosome I (*Chr I*) was amplified as a control for non-specific immunoprecipitation. (**F**, **G**) Quantification of Rpb3p occupancies measured in (E) at the indicated positions at *P~GAL1~-YLR454w* in *hmt1Δ* cells (*F*) and *hmt1Δ* cells containing *npl3RK* (*G*). Average results obtained from two independent cultures and two PCR amplifications for each culture were plotted. (**H**) Possible effect of *hmt1Δ* on Myc-tagged Npl3p and Myc-tagged Np3RKp levels was examined by western blot analysis of WCEs from the relevant strains with antiMyc and antiPgk1p antibodies.

Hmt1p is required for efficient transcription elongation
--------------------------------------------------------

The increased termination at *gal10-Δ56* in *hmt1Δ* cells could result from a decreased transcription elongation rate or increased termination efficiency ([@B9]). In order to dissect the role of Hmt1p in this context, the rate and processivity of transcription elongation were examined in *hmt1Δ* cells by using the ChIP assay to measure occupancies of RNAP II subunit Rpb3p across the *P~GAL1~-YLR454w* gene, in which the ∼8-kb *YLR454w* ORF is placed under the control of the *GAL1* promoter ([Figure 2](#F2){ref-type="fig"}A) ([@B25]). On glucose addition to cells growing in galactose, RNAP II recruitment to the promoter ceases and elongating RNAP II molecules finish transcribing the ORF. The kinetics of Rpb3p disappearance from the ORF during this last wave of elongation represents the elongation rate *in vivo* ([@B22]). Interestingly, it appeared that *hmt1Δ* cells exhibited a moderate decrease in the elongation rate versus wild-type *HMT1* cells, which was evident at 4 min after glucose treatment ([Figure 2](#F2){ref-type="fig"}, panel C versus B). The slower run-off of RNAP II from the *YLR454w* ORF in *hmt1Δ* cells was observed consistently in replicate experiments. To investigate whether the methyltransferase activity of Hmt1p is required for its function in transcription elongation, the ChIP analysis was repeated after introducing plasmid-borne *HMT1* or mutant *hmt1-G68R* into *hmt1Δ* cells. Transformants harboring wild-type *HMT1* exhibited a significantly higher elongation rate than those containing *hmt1-G68R* ([Figure 2](#F2){ref-type="fig"}, Panel F versus E) or empty vector ([Figure 2](#F2){ref-type="fig"}, panel G versus E). Thus, the arginine methyltransferase activity of Hmt1p is required for a wild-type rate of transcription elongation *in vivo*. The lower rate of elongation in *hmt1*Δ cells might contribute to the increased frequency of termination we observed at the defective terminator of *gal10-Δ56*.

Processivity of RNAP II during elongation can be examined by comparing the Rpb3p occupancy at the 5′ and 3′ ends of *YLR454w* in cells grown in galactose ([@B22]). Because no appreciable difference was found in Rpb3p occupancy at *P~GAL1~-YLR454w* between wild-type and *hmt1Δ* cells grown in galactose ([Figure 2](#F2){ref-type="fig"}D), we conclude that elimination of Hmt1p does not produce a detectable decrease in the processivity of elongating RNAP II.

Recruitment of Npl3p and Hrp1p is regulated by the arginine methyltransferase activity of Hmt1p
-----------------------------------------------------------------------------------------------

Apart from stimulating transcription elongation, Hmt1p might reduce recognition of defective terminators by promoting recruitment of Npl3p, or impeding that of Hrp1p, to the transcribed ORF. Hmt1p methylates Npl3p ([@B13]) and Hrp1p ([@B12]), and deletion of *HMT1* provokes accumulation of both proteins in the nucleus ([@B30]), although the accumulation of Hrp1p is dependent on Npl3p ([@B15]). In addition, a genome-wide binding study revealed a slight change in Npl3p genomic occupancy and a more dramatic alteration in Hrp1p recruitment in *hmt1Δ* cells ([@B31]). To determine whether Npl3p and Hrp1p recruitment to a native termination site might be regulated by Hmt1p, ChIP assays were performed to examine the effect of eliminating Hmt1p on occupancy of Npl3p and Hrp1p at *GAL10-GAL7*. Consistent with previous findings ([@B8]), in *hmt1Δ* cells harboring wild-type *HMT1*, Npl3p was found in all regions of *GAL10* ([Figure 3](#F3){ref-type="fig"}B, Lanes 16--20; also see [Figure 3](#F3){ref-type="fig"}C, Lanes 16--20 for quantification). Remarkably, the *hmt1*Δ cells containing empty vector showed greatly reduced Npl3p recruitment ([Figure 3](#F3){ref-type="fig"}B and C, Lanes 1--5 versus 16--20) particularly in the promoter (region A) and middle region (region B) of the *GAL10* ORF ([Figure 3](#F3){ref-type="fig"}B and C, Lanes 1 and 2 versus 16 and 17). Moreover, Npl3p recruitment could not be restored by either *hmt1-G68A* or *hmt1-G68R* ([Figure 3](#F3){ref-type="fig"}B and C, Lanes 6 and 7, and 11 and 12). In agreement with previous findings ([@B13], [@B31]), Western blot analysis revealed no differences in myc-Npl3p levels among these different strains ([Figure 3](#F3){ref-type="fig"}D). These results suggested that the arginine methyltransferase activity of Hmt1p is required for strong Npl3p recruitment to the *GAL10-GAL7* locus.

As Npl3p is thought to function as an antitermination factor by competing with cleavage factors such as Hrp1p for binding to cryptic termination sites ([@B8]), we also examined the effect of eliminating Hmt1p on Hrp1p occupancy at *GAL10-GAL7.* Interestingly, deletion of *HMT1* led to increased Hrp1p recruitment at *GAL10*, particularly to the middle region B ([Figure 3](#F3){ref-type="fig"}B and [3](#F3){ref-type="fig"}E, Lane 2 versus 17). Again, the change in Hrp1p occupancy was dependent on the arginine methyltransferase activity of Hmt1p, as the Hrp1p occupancy in the middle to 3′ region of *GAL10* in *hmt1-G68A* and *hmt1-G68R* cells was higher than in *HMT1* cells ([Figure 3](#F3){ref-type="fig"}B and E, Lanes7--8 and 12--13 versus 17--18). As expected from previous findings ([@B31]), we observed no differences in Hrp1p levels associated with the different *HMT1* alleles ([Figure 3](#F3){ref-type="fig"}F). Thus, although both Npl3p and Hrp1p are concentrated in the nucleus of *hmt1Δ* cells ([@B32]), Npl3p recruitment to the highly transcribed *GAL10-GAL7* locus was reduced, whereas Hrp1p recruitment was increased in *hmt1Δ* cells. Plausibly, Hmt1p could suppress Hrp1p recruitment indirectly by stimulating Npl3p occupancy at *GAL10*. The dramatically decreased ratio of Npl3p to Hrp1p occupancy found in *hmt1Δ* cells ([Figure 3](#F3){ref-type="fig"}C and E) might contribute to the increased recognition of the defective *gal10-Δ56* terminator we observed in *hmt1Δ gal10-Δ56* cells ([Figure 1](#F1){ref-type="fig"}B and C).

Hmt1p regulates Npl3p recruitment, anti-termination and transcription elongation by methylating RGG repeats in Npl3p
--------------------------------------------------------------------------------------------------------------------

Replacing all 15 RGG repeats in Npl3p with KGG repeats partially mimics the effect of methylation by Hmt1p and facilitates Npl3p dissociation from Tho2p and nuclear export in *hmt1Δ* cells ([@B12],[@B13]). We wished to determine whether the KGG substitutions in Npl3RKp would also reduce the requirement for Hmt1p in efficient Npl3p recruitment, as this would imply that Hmt1p stimulates Npl3p recruitment directly by methylating RGG repeats. In agreement with results in [Figure 3](#F3){ref-type="fig"}, deletion of *HMT1* impaired Npl3p recruitment to *GAL10-GAL7* ([Figure 4](#F4){ref-type="fig"}A, Lanes 6--10 versus 1--5). Interestingly, however, recruitment of Npl3RKp was considerably less dependent on Hmt1p than is wild-type Npl3p ([Figure 4](#F4){ref-type="fig"}A, Lanes 11--15 versus 6--10). Comparing Npl3RKp recruitment in *hmt1Δ* cells to that of wild-type Npl3p in *HMT1* cells reveals lower occupancies for Npl3RKp at the 5′ and middle regions of *GAL10* (regions A and B, respectively) ([Figure 4](#F4){ref-type="fig"}A, Lanes 11--12 versus 1--2)*,* but similar occupancies in the 3′ region of *GAL10* and promoter region of *GAL7* (regions D and E, respectively) ([Figure 4](#F4){ref-type="fig"}A, Lanes 14--15 versus 4--5). In agreement with previous findings ([@B13], [@B31]), western analysis indicated that there are no differences in expression levels of myc-Npl3p or myc-npl3RKp among the three strains ([Figure 4](#F4){ref-type="fig"}H). These findings suggested that Npl3RKp might function as an antitermination factor in *hmt1Δ* cells as effectively as wild-type Npl3p does in *HMT1* cells.

To address this possibility, we first asked whether the KGG substitutions would impair the antitermination function of Npl3p. As described in our previous study ([@B23]), *npl3*Δ suppressed the Gal^−^ phenotype conferred by *gal10-Δ56*, allowing modest growth on YP+Gal medium ([Figure 4](#F4){ref-type="fig"}B, right panel, Row 4 versus 3) despite the fact that *npl3*Δ confers a strong slow growth phenotype on this medium even in the presence of wild-type *GAL10* ([Figure 4](#F4){ref-type="fig"}B, right panel, Row 2 versus 1). Importantly, the *npl3RK* mutant was indistinguishable from wild-type *NPL3* in reversing the ability of *npl3*Δ *gal10-Δ56* cells to grow on YP+Gal ([Figure 4](#F4){ref-type="fig"}B, right panel, Rows 7--8 versus 4), as well as in complementing the slow growth phenotype of *npl3*Δ*GAL10* cells in this medium ([Figure 4](#F4){ref-type="fig"}B, right panel Rows 5 and 6 versus 2). In line with the Gal^−^ phenotypes, northern blot analysis showed that both *npl3RK* and *NPL3* conferred a strong reduction in *GAL7* mRNA and elevated levels of *GAL10-GAL7 RT* transcripts in *npl3*Δ *gal10-Δ56* cells ([Figure 4](#F4){ref-type="fig"}C, Lanes 4--5 versus 3). In fact, *npl3RK* provoked a lower *GAL7/RT* ratio than did wild-type *NPL3* ([Figure 4](#F4){ref-type="fig"}C, Lane 4 versus 5), indicating that Npl3RKp actually has a higher level of antitermination activity than wild-type Npl3p.

Having found that Npl3RKp has antitermination function and is recruited independently of Hmt1p, we tested whether Npl3RKp could suppress the reduced antitermination phenotype in *hmt1Δ* cells. In agreement with our findings in [Figure 1](#F1){ref-type="fig"}B, *hmt1Δ* partially suppressed the Gal^−^ phenotype of *gal10Δ-56* cells, which we attributed to increased recognition of the defective *GAL10* terminator and greater production of *GAL7* mRNA ([Figure 1](#F1){ref-type="fig"}C). Interestingly, over-expression of Npl3RKp but not wild-type Npl3p, reversed this effect of *hmt1*Δ and restored the Gal^−^ phenotype in *hmt1Δgal10Δ-56* cells ([Figure 4](#F4){ref-type="fig"}D, Rows 5 versus. 3, and Rows 4 versus 3). This finding suggests that the antitermination function of Npl3RKp is independent of Hmt1p.

We also asked whether Npl3RKp could rescue the transcription elongation defect in *hmt1Δ* cells. Using the same ChIP assay employed in [Figure 2](#F2){ref-type="fig"} to measure the transcription elongation rate at *P~GAL1~-YLR454w*, we found that overexpressing Npl3RKp significantly reduced the elongation defect in *hmt1Δ* cells ([Figure 4](#F4){ref-type="fig"}E--G), while this was not observed in cells over-expressing wild-type Npl3p (data not shown).

Methylation of Npl3p by Hmt1p facilitates co-transcriptional recruitment of THO/TREX
------------------------------------------------------------------------------------

There is evidence that Hmt1p methylation of Npl3p reduces its interaction with transcription elongation factor Tho2p ([@B13],[@B31]), and that the KGG substitutions in Npl3p partially bypass the requirement for Hmt1p in reducing Npl3p-Tho2p association ([@B13]). We hypothesized that the elongation defect in *hmt1Δ* cells involves sequestration of Npl3p and Tho2p in nuclear mRNPs that are not competent for export with attendant impairment of Tho2p recruitment by elongating RNAP II. Consistent with this idea, ChIP analysis showed that cells lacking Hmt1p or containing Hmt1p variants lacking arginine methyltransferase activity displayed reduced Tho2p occupancy in the middle region of the *GAL10* ORF compared with that seen in cells containing wild-type Hmt1p ([Figure 5](#F5){ref-type="fig"}A, Lanes 1--3 versus 4). Importantly, over-expression of Npl3RKp, but not Npl3p, restored Tho2p recruitment in *hmt1Δ* cells to the same level observed in *HMT1* cells with native levels of Npl3p ([Figure 5](#F5){ref-type="fig"}A, Lanes 5--6 versus 1 and 4). This effect was not due to differences in RNAP II occupancy at *GAL10* in these strains (see comment) or Tho2p expression level (data not shown) ([@B13]). These findings support the idea that the transcription elongation defect in *hmt1Δ* cells involves binding of non-methylated Npl3p to the THO or TREX complex, thereby reducing the recruitment of one or both of these elongation factor complexes to elongating RNAP II. Figure 5.Tho2p recruitment and gene length-dependent transcription defects in *hmt1Δ* cells are suppressed by *npl3RK*, and a hypothetical model for the role of Hmt1p in recycling Tho2p and Npl3p from mRNPs to sites of transcription. ChIP analysis of Tho2p occupancy at the 5′ region of *GAL10* gene (region B in [Fig. 3](#F3){ref-type="fig"}A) in *hmt1Δ THO2-myc~13~* (CMY202) cells. Cells transformed with empty vector, or plasmids containing *hmt1-G68A*, *hmt1-G68R*, *HMT1*, *NPL3* or *npl3RK* were grown in SC-LEU with 2% galactose and ChIP analysis was conducted using antiMyc antibodies (to measure Tho2p occupancy) or antibodies against Rpb3p (to measure RNAP II occupancy). Non-coding region on chromosome V (*Chr V*) was amplified as control for non-specific immunoprecipitation. The occupancies were quantified and plotted for Tho2p (**A**) and Rpb3p (**B**). Average results obtained from two independent cultures and two PCR amplifications for each culture were plotted. The occupancies of Tho2p at the *GAL10 ORF* are significantly lower in control (*hmt1Δ*), *G68A* and *G68R* versus *HMT1* cells, and in cells containing extra copies of *NPL3* versus extra copies of *npl3RK*, as judged by the Student's *t*-test, with *P* \< 0.01(\*). (**C**) *HMT1* (BY4741) and *hmt1*Δ (3171) cells transformed with reporter plasmid pSCH209-*LAC4* plus plasmids harboring *hmt1-G68A*, *NPL3, npl3RK* or empty vector were grown in SC-LEU-URA with 2% galactose. *HMT1* (BY4741) and *hmt1Δ* (3171) cells harboring pSCH202 were analyzed as controls. Acid phosphatase activity was measured in cell lysates and the GLAM ratio was calculated as the ratio of activities in transformants harboring pSCH209-*LAC4* versus those containing pSCH202. Results are the averages from three independent experiments and error bars indicate SD (**D**) Model depicting how Hmt1p regulates transcription elongation and termination by methylating Npl3p. *Upper panel*: In *WT* cells, methylation of Npl3p by Hmt1p allow dissociation the TREX(Tho2p)−Npl3p−mRNP to facilitate ([@B1]) TREX(Tho2p) recruitment to sites of transcription and ([@B2]) nuclear export of the Npl3p−mRNP. Subsequent nuclear import and methylation of Npl3p by Hmt1p enables its recruitment to sites of transcription ([@B3]). Npl3p and TREX both stimulate elongation and, by impeding recruitment of Hrp1p ([@B4]), Npl3p prevents transcription termination at cryptic terminators. *Middle panel*, in *hmt1Δ NPL3* cells, the failure to methylate Npl3p causes Tho2p (TREX) and Npl3p to be sequestered in mRNPs that are not exported efficiently; the ensuing impaired recruitment of TREX(Tho2p) and Npl3p to sites of transcription reduces the rate of elongation, and the resulting increased Hrp1p occupancy enables transcription termination at cryptic terminators. *Lower panel*, in *hmt1Δ npl3RK* cells, TREX(Tho2p)-Npl3RKp-mRNP can dissociate independently of Npl3p methylation to recycle TREX(Tho2p) and Npl3RKp back to sites of transcription where they stimulate elongation and block termination at cryptic terminators, as occurs in *WT* cells.

Finally, we employed an assay for gene-length dependent accumulation of mRNA (GLAM), which reveals defects in transcription elongation, to provide further support that Hmt1p stimulates elongation by methylating Npl3p. The GLAM assay compares the expression of reporters with the same promoter (*P~GAL~*) and *PHO5* coding sequences for acid phosphatase, but harboring 3′ untranslated regions that differ by 3 kb. Mutations in elongation factors produce a greater reduction in the steady-state amount of the long versus short transcript, and their encoded Pho5p enzyme activities (decreased GLAM ratio) ([@B25]). In agreement with our findings from the kinetic ChIP assay in [Figures 2](#F2){ref-type="fig"}, and [4](#F4){ref-type="fig"}, we found that *hmt1Δ* cells exhibit a significantly lower GLAM ratio than do *HMT1* cells ([Figure 5](#F5){ref-type="fig"}C, Lanes 1 versus 4), and the reduced GLAM ratio of *hmt1*Δcells was complemented with plasmid-borne *HMT1* but not by *hmt1G68R* ([Figure 5](#F5){ref-type="fig"}C, Lanes 5--6 versus 4). Importantly, the reduced GLAM ratio of *hmt1Δ* cells was suppressed by over-expressing *npl3RK*, but not by over-expressing wild-type *NPL3* ([Figure 5](#F5){ref-type="fig"}C, Lanes 7--8 versus 4).

DISCUSSION
==========

Achieving efficient transcription termination at the correct termination sites and blocking termination at cryptic terminators involves a complex interplay between elongation factors, anti-termination factors and termination factors, all recruited by elongating RNAP II ([@B8],[@B10]). In this study, we have explored the role of arginine methylation by Hmt1p in regulating the transition from transcription elongation to termination. We obtained evidence that Hmt1p suppresses recognition of the mutationally weakened terminator at *gal10-Δ56* ([Figure 1](#F1){ref-type="fig"}) and set out to elucidate the mechanism of its antitermination activity. The increased termination at *gal10-Δ56* in *hmt1Δ* cells could arise from less efficient transcription elongation, diminished recruitment of an antitermination factor or increased recruitment of a termination factor. We found evidence for all three mechanisms. Results from two different *in vivo* assays revealed that mutants lacking Hmt1p or impaired for its arginine methyltransferase activity exhibit transcription elongation defects ([Figure 5](#F5){ref-type="fig"}C), involving a reduced rate of elongation ([Figure 2](#F2){ref-type="fig"}). This is noteworthy because, apart from mutation of RNAP II itself, inactivation of various elongation factors was not found to reduce the elongation rate *in vivo* ([@B22]).

The *hmt1* mutants also display decreased recruitment to *GAL10* of the antitermination factor Npl3p, known to block recognition of the defective *gal10-Δ56* terminator ([@B8]), and they further exhibit elevated occupancies of cleavage/termination factor Hrp1p ([Figure 3](#F3){ref-type="fig"}). A previous genome-wide analysis did not reveal an important role for Hmt1p arginine methyltransferase activity in modulating co-transcriptional recruitment of Npl3p or Hrp1p, although a non-enzymatic function of Hmt1p was implicated in down-regulating Hrp1p recruitment at many genes ([@B31]). Perhaps the marked effects of Hmt1p catalytic function on Npl3p and Hrp1p recruitment observed here are restricted to highly induced genes like *GAL10*.

Substituting all of the RGG repeats in Npl3p with KGG (in the Npl3RKp variant) was shown previously to mimic the effects of Hmt1p on nuclear export of Npl3p and its interaction with Tho2p ([@B12],[@B13]). Interestingly, we found that the KGG substitutions also partially rescue Npl3p recruitment to *GAL10* ([Figure 4](#F4){ref-type="fig"}A) and, consistently, restore the antitermination function of Npl3p at *gal10-Δ56* in *hmt1Δ* cells ([Figure 4](#F4){ref-type="fig"}D). Remarkably, overexpressing Npl3RKp also rescues efficient recruitment of Tho2p ([Figure 5](#F5){ref-type="fig"}A) and mitigates the transcription elongation defects in *hmt1*Δ cells ([Figure 4](#F4){ref-type="fig"}E--G and [Figure 5](#F5){ref-type="fig"}C). The fact that substituting the RGG repeats in Npl3p suppresses the effects of *hmt1*Δ on antitermination, elongation and recruitment of Npl3p implies that Hmt1p influences all of these events by methylating Npl3p rather than another substrate. The ability of the KGG substitutions to rescue Npl3p recruitment and transcription elongation fits with previous findings that Npl3p directly stimulates elongation by purified RNAP II ([@B11]). However, the reduced recruitment of elongation factor Tho2p might also contribute to the elongation defect in *hmt1Δ* cells, as Tho2p recruitment was likewise rescued by overexpressing Npl3RKp ([Figure 5](#F5){ref-type="fig"}A). This last result is consistent with previous findings that Npl3p, but not Npl3RKp, is bound tightly to Tho2p in an mRNP complex in *hmt1Δ* cells. It was proposed that Hmt1p methylation of Npl3p is required for its dissociation from Tho2p and other TREX components to facilitate nuclear export of the Npl3p-mRNP complex ([@B13],[@B31]).

Based on our findings and the previous results, we propose that methylation of the RGG repeats in Npl3p by Hmt1p facilitates mRNA export and leads to dissociation of TREX (Tho2p) from Npl3p-containing mRNPs recycling TREX (Tho2p) back to sites of transcription where it can stimulate elongation. Following mRNA export, the Npl3p re-enters the nucleus, and is methylated by Hmt1p ([Figures 3](#F3){ref-type="fig"}C and [4](#F4){ref-type="fig"}A). Methylated Npl3p is recruited co-transcriptionally to enhance elongation and also block recruitment of CFI at cryptic terminators ([Figure 5](#F5){ref-type="fig"}D, top panel). In *hmt1Δ* cells, the TREX--Npl3p--mRNA complex persists in the nucleus ([@B13],[@B31]) and co-transcriptional recruitment of both Npl3p and THO/TREX complex are diminished, thereby reducing the elongation rate and increasing utilization of cryptic terminators ([Figure 5](#F5){ref-type="fig"}D, middle panel). The KGG substitutions in Npl3p partially rescue mRNA export and thereby dissociate TREX from the Npl3p--mRNA complexes independently of Npl3p methylation by Hmt1p, thus suppressing the elongation and antitermination defects of *hmt1Δ* cells ([Figure 5](#F5){ref-type="fig"}D, bottom). This model is consistent with the finding that the defect in mRNA nuclear export in *hmt1Δ* cells is rescued by overexpressing Npl3RKp ([@B13]). It is also supported by the fact that the transient Tho2p--Npl3p--mRNA complex has been detected by coimmunoprecipitation only in *hmt1Δ* cells, which are defective for mRNA nuclear export ([@B13]). Methylation of Npl3p might enhance its recruitment to sites of elongation by another more active mechanism besides dissociation of the putative TREX--Npl3p--mRNA complex postulated in our model.

The proposed role of Hmt1p in regulating interaction of Tho2p and Npl3p on nascent mRNAs may provide a feedback mechanism for coordinating the rate of transcription elongation with nuclear export. If methylation of Npl3p is required to enable nuclear export of the Npl3p--mRNP and recycle TREX (Tho2p), as suggested in [Figure 5](#F5){ref-type="fig"}D, then the availability of TREX (Tho2p) for new rounds of transcription elongation will be dependent on the completion of mRNA export of existing nascent transcripts.

In addition to methylation, Npl3p can be phosphorylated by Sky1p ([@B14],[@B15],[@B33]) and CK2 ([@B11]). Phosphorylation of Npl3p (on Ser-411) by Sky1p reduces Npl3p RNA binding affinity and promotes Npl3p dissociation from mRNA ([@B14]). Hence, it is thought that phosphorylation of Npl3p by Sky1p in the cytoplasm is important for recycling Npl3p back to the nucleus ([@B14],[@B15],[@B33]) and releasing the transcripts for translation ([@B34]). However, there is evidence that Npl3p methylation by Hmt1p antagonizes Sky1p-mediated phosphorylation of Npl3p *in vitro* ([@B15]). Therefore, an unknown Npl3p demethylase might have to operate in the cytoplasm to permit Sky1p phosphorylation of Npl3p. Interestingly, Npl3p is also phosphorylated on Ser-411 by CK2 in the nucleus ([@B11]). This phosphorylation is suggested to promote Npl3p dissociation from the nascent transcript, and hence promote the recruitment of termination factors ([@B11]). Our results indicate that the Npl3p recruited to sites of transcription is methylated by Hmt1p ([Figures. 3](#F3){ref-type="fig"}C and [4](#F4){ref-type="fig"}C). Since CK2 phosphorylates the same site as Sky1p, it is possible that Npl3p methylation would also antagonize CK2-mediated phosphorylation at Ser-411 and prevent the proposed function in dissociation of Npl3p at termination sites. It is unclear whether methylation of Npl3p would antagonize its phosphorylation by CK2 *in vivo* and the attendant proposed effects of CK2 on termination. It is clearly of great interest to fully elucidate the sequence and precise timing of post-translational modifications of Npl3p (including methylation, demethylation, phosphorylation and dephosphorylation) during the transcription cycle, splicing and mRNA export.

The human homologue of yeast Hmt1p, Prmt1p, was suggested to affect transcription elongation via methylation of Spt5p ([@B35]) and histone H4 Arg-3 ([@B36],[@B37]). Presumably Npl3RKp does not affect the methylation of other molecules in *hmt1Δ* cells, and thus Npl3RKp likely rescues the transcription elongation defect conferred by *hmt1Δ* through mechanisms distinct from those described for Prmt1p, e.g. by promoting TREX (Tho2p) recruitment ([Figure 5](#F5){ref-type="fig"}D). Hmt1p might also stimulate elongation via methylation of Npl3p by enhancing recruitment of Npl3p to elongating RNAP II, as Npl3p can stimulate elongation in a purified system lacking TREX ([@B11],[@B30]).

In summary, we have provided the first direct evidence that the arginine methyltransferase activity of Hmt1p enhances transcription elongation and antitermination *in vivo* and that both functions involve its methylation of RGG repeats in Npl3p, enhancing recruitment of Npl3p and THO/TREX while impeding recruitment of CFI to sites of transcription elongation.
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[^1]: \*The plasmids express protein A (PrA) fusion protein driven by *NOP1* promoter.

[^2]: \*The sequence of this oligonucleotide was re-designed in this study.
